Home Regenerative Medicine for Morton’s Neuroma | Myelin Repair & Nerve Healing

Regenerative Medicine for Morton’s Neuroma | Myelin Repair & Nerve Healing

Regenerative Medicine & Morton’s Neuroma Surgery

Why Surgery Alone May Not Be Enough

When a nerve has been compressed for months or years, the damage extends well beyond the point of entrapment. The myelin sheath — the protective insulating layer surrounding the nerve fiber — breaks down under sustained pressure. This process, called demyelination, disrupts nerve signal transmission and is a major reason why patients continue to feel burning, numbness, or hypersensitivity even after the mechanical compression has been relieved.

Nerve decompression surgery removes the source of compression. But the nerve itself still has repair work to do. The myelin sheath must regenerate, inflammation must resolve, and the surrounding tissue environment must support healing — not fight it.

This is where regenerative medicine plays a critical role.

What Regenerative Medicine Adds to Nerve Surgery

Dr. Bregman uses placental-derived and amniotic tissue allografts — commonly referred to as placental tissue or regenerative biologics — delivered directly to the surgical site at the time of decompression. These products contain a rich concentration of growth factors, cytokines, and extracellular matrix components that support nerve regeneration and tissue repair.

Specifically, these biologics work to:

  • Accelerate myelin sheath repair — providing the biological scaffolding and signaling molecules the nerve needs to rebuild its protective coating
  • Reduce post-operative inflammation — dampening the inflammatory response that can otherwise slow nerve recovery and contribute to persistent pain
  • Support axonal regeneration — encouraging healthy nerve fiber regrowth and improved signal conduction
  • Create a favorable healing environment — the extracellular matrix components in placental tissue help guide and sustain the tissue repair process

The result is that the nerve has a better environment in which to heal, and patients typically experience faster, more complete resolution of symptoms after surgery.

Especially Important for Long-Standing Compression

The longer a nerve has been compressed, the more myelin damage has accumulated. Patients who have suffered with Morton’s neuroma symptoms for a year or more — or who have gone through multiple rounds of injections and conservative treatments — often have significant myelin sheath degradation by the time they reach surgery.

For these patients, simply releasing the compression may not be sufficient on its own. Adding regenerative biologics at the time of surgery directly addresses the underlying nerve damage, not just its mechanical cause.

Regenerative Medicine in Revision and Neurectomy Cases

For patients who have undergone a prior neurectomy elsewhere and are now dealing with a stump neuroma or persistent pain, regenerative medicine serves an additional and equally important function: scar tissue management.

After a neurectomy, the nerve stump retracts into the surrounding soft tissue. Scar tissue forms around the stump end, and in many cases this scar tissue becomes the new source of pain — compressing, entrapping, or irritating the nerve remnant. Repeat surgery in a previously operated field is always more complex because of this scarring.

Delivering placental tissue to the revision surgical site does two things:

  • Retards scar tissue formation — the anti-fibrotic properties of amniotic and placental allografts help prevent aggressive scar tissue from re-forming around the nerve stump
  • Supports healing in a compromised environment — revision sites have disrupted blood supply and altered tissue planes; regenerative biologics help restore a more favorable healing environment in tissue that has already been through surgery once

This is why Dr. Bregman routinely incorporates regenerative biologics into revision procedures for failed neurectomy cases — not as an optional add-on, but as a standard part of the surgical approach.

What These Products Are — and What They Are Not

Placental tissue allografts are derived from donated human placental tissue, processed and sterilized to remove cellular components while preserving the growth factors and extracellular matrix. They are FDA-regulated as human tissue products. They are not experimental, and they are not the same as embryonic stem cell therapy.

These products have been used in surgical settings for wound healing, orthopedic repair, and nerve surgery for over a decade and have a well-established safety profile.

Is Regenerative Medicine Right for Your Case?

Dr. Bregman evaluates each patient individually. The decision to incorporate regenerative biologics is based on the duration of symptoms, the degree of nerve damage, whether prior surgery has been performed, and the findings at the time of surgery.

If you are considering nerve decompression for Morton’s neuroma, or if you have had a prior neurectomy and are still experiencing pain, a specialist evaluation can help determine whether a regenerative approach is appropriate for your situation.

Schedule a Consultation with Dr. Bregman →


Related Resources